[
    [
        {
            "time": "2018-01-03",
            "original_text": "Q4 Earnings Season Scorecard and Analyst Reports for Exxon, AbbVie & Caterpillar",
            "features": {
                "keywords": [
                    "Q4",
                    "Earnings",
                    "Season",
                    "Exxon",
                    "AbbVie",
                    "Caterpillar"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "energy",
                    "healthcare",
                    "industrials"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Q4 Earnings Season Scorecard and Analyst Reports for Exxon, AbbVie & Caterpillar",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 9,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-01-04",
            "original_text": "Here is Why Growth Investors Should Buy AbbVie (ABBV) Now",
            "features": {
                "keywords": [
                    "Growth",
                    "Investors",
                    "Buy",
                    "AbbVie"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Here is Why Growth Investors Should Buy AbbVie (ABBV) Now",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 7,
                "Impact": 8,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-01-05",
            "original_text": "What Makes AbbVie (ABBV) a New Buy Stock",
            "features": {
                "keywords": [
                    "AbbVie",
                    "Buy",
                    "Stock"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "What Makes AbbVie (ABBV) a New Buy Stock",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-01-06",
            "original_text": "ABBV or LLY: Which Is the Better Value Stock Right Now?",
            "features": {
                "keywords": [
                    "ABBV",
                    "LLY",
                    "Value",
                    "Stock"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "ABBV or LLY: Which Is the Better Value Stock Right Now?",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 6,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-01-07",
            "original_text": "Novartis (NVS) Gets Breakthrough Therapy Tag for Leukemia Drug",
            "features": {
                "keywords": [
                    "Novartis",
                    "Breakthrough",
                    "Therapy",
                    "Leukemia",
                    "Drug"
                ],
                "sentiment_score": 0.95,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Novartis (NVS) Gets Breakthrough Therapy Tag for Leukemia Drug",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-01-08",
            "original_text": "Invitation to media - Minister Mélanie Joly to announce investments to support innovative Centre-du-Québec manufacturers",
            "features": {
                "keywords": [
                    "Invitation",
                    "media",
                    "Minister",
                    "Mélanie Joly",
                    "investments",
                    "Centre-du-Québec",
                    "manufacturers"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "manufacturing"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Invitation to media - Minister Mélanie Joly to announce investments to support innovative Centre-du-Québec manufacturers",
                "Correlation": 2,
                "Sentiment": 5,
                "Importance": 4,
                "Impact": 3,
                "Duration": 3,
                "Entity_Density": 1,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 5,
                "Source_Recency": 6
            }
        }
    ]
]